论文部分内容阅读
NAVIGATOR(Nateglinide And Valsartanin Impaired Glucose Toler-ance Outcomes Research)〔1〕是评价降糖药物那格列奈和降压药物血管紧张素Ⅱ受体拮抗剂缬沙坦对糖耐量受损(IGT)患者预后干预的试验研究,主要包括四方面的内容:①那格列奈是否阻止或延缓IGT发展成为2型糖尿病;
NAVIGATOR (Nateglinide And Valsartanin Impaired Glucose Toler-ance Outcomes Research) 〔1〕 is to evaluate the antidiabetic drugs nateglinide and antihypertensive drugs angiotensin Ⅱ receptor antagonist valsartan impaired glucose tolerance (IGT) patients with prognosis The pilot studies on intervention mainly include four aspects: (1) whether nateglinide prevents or delays the development of IGT into type 2 diabetes;